Your session is about to expire
← Back to Search
DEMA Intervention for Mild Cognitive Impairment (PRIMA Trial)
PRIMA Trial Summary
This trial is testing whether the DEMA intervention can improve life satisfaction and health outcomes for patients and caregivers, compared to the attention control group.
PRIMA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPRIMA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PRIMA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am over 18, care for someone with MCI, speak English, and am mentally oriented.I am over 59, speak English, have memory concerns, a MoCA score of 15-25, and can do daily tasks without help.I do not have severe depression, advanced cancer treatment, dialysis, severe hearing loss without aids, lack of phone access, or a caregiver with significant cognitive issues.
- Group 1: Information Support (IS)
- Group 2: Daily Engagement Meaningful Activity (DEMA)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have been approved for this research project?
"Affirmative. According to the information on clinicaltrials.gov, this experiment was initially posted on December 13th 2021 and is actively searching for suitable candidates with a goal of 400 patients at one site. The trial has been updated as recently as October 21st 2022."
Is there a possibility that I could participate in this research endeavor?
"Qualified individuals should present with mild cognitive impairment (MCI) and be aged between 18-100. At this time, the trial is looking to recruit around 400 participants."
Is this trial actively seeking new participants?
"This trial, which was initially made available on December 13th 2021 and has most recently been updated October 21st 2022, is actively searching for potential participants."
Is the study open to applicants younger than 75 years old?
"The recruitment effort for this medical trial calls out to individuals aged 18 and above, up until the age of 100."
Share this study with friends
Copy Link
Messenger